Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection

AIDS

Volumn 14, Issue 18, 2000, Pages 2831-2839

  Putter, Hein ^a   Prins, Jan M ^a   Jurriaans, Suzanne ^a   Roos, Marijke ^a   Ferguson, Neil M ^b   Van Praag, Rieneke ^a   Van der Hoek, Lia ^a   Schuitemaker, Hanneke ^a   Anderson, Roy M ^b   Goudsmit, Jaap ^a   Lange, Joep M A ^a   De Wolf, Frank ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acute infection; Antiretroviral therapy; Chronic infection; HIV clearance; Viral load

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; NEVIRAPINE; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

ACUTE DISEASE; ADULT; ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; VIRAL LOAD;

EID: 0034523272     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200012220-00004     Document Type: Article

References (31)

1. High liters of cylopathic virus in plasma of patients with symptomatic primary HIV-1 infection
2. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection
3. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type I syndrome
4. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type t infection
5. Vigorous HIV-1 specific CD4 T-cell responses associated with control of viremia
6. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type t infection
7. Acute AIDS retrovirus infection: Definition of a clinical illness associated with seroconversion
8. Influenza-like syodrome in homosexual men: A prospective diagnostic study
9. Diagnostic value of specific IgM antibodies in primary HIV infection
10. Clinical and epidemiologic features of primary HIV infection
11. Reduction of HIV concentration during acute infection: Independence from a specific immune response
12. Patterns of viral dynamics during primary human immunodeficiency virus type I infection
13. Natural history of HIV-1 cell-free viremia
14. Viral counts count in HIV infection
15. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
16. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: Markers with reciprocal predictive value over time after seroconversion
17. Biological and virological characteristics of primary HIV infection
18. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel
19. Alternative multidrug regimen provides improved suppression of HIV-1 replication over triple therapy
20. Time to hit HIV, early and hard
21. Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy
22. Rapid and simple method for purification of nucleic acids
23. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: Development of HLA-DR+ CD38-CD8+ cells is associated with subsequent stable CD4+ cell levels
24. Rapid quantification of indinavir in human plasma by high-performance liquid chromatography with ultraviolet detection
25. Random-effects models for longitudinal data
26. Nonlinear mixed effects models for repeated measures data
27. Antigen-driven CD4+ T cell and HIV-1 dynamics: Residual viral replication under highly active antiretroviral therapy
28. Intervention with quadruple HAART [Combivir (COM)/Abacavir (A8C)/Amprenavir (APV)] Intervention during primary HIV-1 infection (PHI) is associated with rapid viremia clearance and decrease of immune activation
29. The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type I infection on viral replication and antiviral immune responses
30. Viral load and burden modification following early antiretroviral therapy of primary HIV-1 infection
31. Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen